Addressing the unique medication needs of older adults with depression

Depression in later life rarely presents as a single, neatly defined condition. An older person may describe poor sleep, persistent pain, low appetite, dizziness or memory problems rather than saying they feel depressed. Medication decisions therefore need to account for physical illness, frailty, cognitive changes, social isolation and the practical realities of taking medicines every day.

Older adults also respond differently to antidepressants and other medicines. Age-related changes in kidney and liver function can increase exposure to active ingredients, while falls, constipation, hyponatraemia, bleeding and delirium may become more likely. A medicine that was tolerated at 55 may be unsuitable at 80, particularly when several prescriptions are involved.

For Australian pharmacists, safe care sits within a wider system involving general practices, hospitals, residential aged-care services, carers and community supports. PBS restrictions, dose administration aids, My Health Record, medicine reviews and the distance between services in rural areas can all influence whether a treatment plan works in real life.

Recognising how depression appears in later life

Depression may be overlooked when symptoms are attributed to ageing, bereavement or chronic disease. A person with heart failure may report tiredness; someone with arthritis may stop attending social activities because movement is painful; another person may present repeatedly with headaches or gastrointestinal complaints. Pharmacists who know a patient’s usual behaviour can notice changes that are not obvious in a brief medical appointment.

Key signs include a loss of interest, reduced self-care, unexplained weight change, slowed thinking, disrupted sleep, irritability and increasing reliance on alcohol or sedating medicines. Cognitive symptoms can be especially confusing. Depression can produce poor concentration and forgetfulness, while dementia can coexist with low mood. A sudden decline, fluctuating confusion or marked drowsiness requires assessment for delirium, infection, medicine toxicity and other urgent causes rather than an assumption that the person simply needs an antidepressant.

A private, respectful conversation at the pharmacy counter can open a path to care. Simple observations such as “You seem less steady than usual” or “How have you been managing since your last prescription?” may be more effective than a checklist delivered rapidly. If there is hopelessness, thoughts of death, self-neglect or concern about immediate safety, the pharmacist should follow local escalation procedures and involve the GP, crisis services, carers or emergency services as appropriate.

Reviewing antidepressants alongside the whole regimen

Medication review should begin with the full list, including prescribed medicines, over-the-counter products, complementary medicines, alcohol and medicines borrowed from family members. Sedating antihistamines, benzodiazepines, opioids, gabapentinoids and some bladder medicines can worsen falls, confusion or low mood. NSAIDs and antiplatelet medicines may increase bleeding risk when combined with some antidepressants, while diuretics and other medicines can contribute to low sodium.

Selective serotonin reuptake inhibitors are commonly used in older adults, but “commonly used” does not mean risk-free. Fluoxetine has a long half-life and can complicate switching or adverse-effect management. Paroxetine has anticholinergic properties and may be a poor choice for a person with constipation, urinary retention or cognitive impairment. Citalopram and escitalopram require attention to dose and QT prolongation risk, particularly in people with cardiac disease or electrolyte abnormalities. Sertraline is often considered when cardiac safety and interaction burden are important, yet individual assessment remains essential.

Starting low and increasing gradually can reduce early adverse effects, although the dose should not remain too low indefinitely if symptoms persist. Patients and carers need clear information about expected timing: some changes, such as nausea or sleep disturbance, may occur early, while mood improvement can take several weeks. Follow-up should assess function, mood, adherence, falls, appetite, sleep, agitation and suicidal thinking rather than relying only on whether the patient says the medicine is “working”.

Pharmacists may also encounter situations where a prescription appears unsafe, unclear or inconsistent with the patient’s current condition. A structured discussion of ethical dispensing decisions can help frame the balance between continuity of care, professional responsibility and immediate risk. Refusing supply is not the only response; contacting the prescriber, supplying an appropriate interim quantity, documenting concerns and arranging urgent review may be safer solutions.

Medication-related concern	What to assess in an older person	Practical pharmacy response
Falls or daytime sedation	Benzodiazepines, opioids, gabapentinoids, antihistamines and alcohol	Review timing, duplication and necessity; refer for a broader medication review
Low sodium or worsening confusion	SSRIs, diuretics, poor intake and recent illness	Escalate new confusion, weakness or unsteadiness for medical assessment
Bleeding	Antidepressants with anticoagulants, antiplatelets or NSAIDs	Check for bruising, black stools and falls; communicate concerns promptly
Poor adherence	Complex regimens, low vision, tremor, memory impairment or depression-related apathy	Consider dose administration aids, carer support, simplified dosing and follow-up
Treatment failure	Wrong diagnosis, inadequate duration, interactions, alcohol use or missed doses	Confirm how the medicine is taken and arrange review rather than automatically increasing the dose
Discontinuation symptoms	Abrupt cessation after long-term use	Explain tapering and coordinate a planned change with the prescriber

Making treatment workable at home and in aged care

Adherence is often a design problem rather than a motivation problem. A person living alone in Ballarat may manage a weekly blister pack well, while someone in a remote community near Broome may face delivery delays, limited transport and difficulty accessing a prescriber. A medication plan should fit the person’s eyesight, dexterity, memory, hearing, language, routine and support network.

Dose administration aids can reduce confusion, but they do not solve every problem. A patient may remove tablets from the pack and forget whether they have taken them, or become too nauseated to continue eating and taking medicines. Pharmacists should check whether the aid is being used correctly, whether medicines remain suitable for packing and whether the patient can explain the purpose of key medicines. Large-print instructions, translated information, reminder calls and carer involvement may be more useful than adding another device.

In residential aged care, communication between the facility, prescriber and pharmacy is central. Staff should know which effects require prompt escalation, including new agitation, worsening withdrawal, falls, refusal of food, excessive sedation or suicidal statements. Regular medication management reviews can identify medicines that were appropriate during an acute episode but now carry greater risk. Deprescribing should be gradual and monitored, especially after long-term benzodiazepine or antidepressant use.

Australia’s PBS and local supply arrangements also shape treatment choices. A medicine may be clinically reasonable but difficult to obtain, expensive outside subsidy arrangements or unavailable in the strength needed for a gradual taper. Rural and remote pharmacies may need to plan ahead for stock, cold-chain requirements and delayed deliveries. In Aboriginal and Torres Strait Islander communities, culturally safe care, local health workers and community-controlled services should be part of the conversation rather than an afterthought.

Coordinating care and monitoring outcomes

A written care plan should identify the prescriber, pharmacist, carer and other professionals involved, as well as the follow-up date and the symptoms that require earlier contact. With patient consent and appropriate privacy safeguards, My Health Record can support information sharing, although pharmacists should not assume it contains a complete or current medication list. Direct communication with the GP remains important when there has been a hospital admission, medicine change or significant adverse effect.

Medication reviews are most useful when they answer practical questions. Is the person taking the intended dose? Have they missed doses because of cost, confusion or adverse effects? Are they still driving? Have they fallen? Are they using alcohol to sleep? Has pain improved enough to support activity? A numerical mood scale may help track change, but functional outcomes—showering, shopping, attending appointments, preparing food and reconnecting with others—often reveal whether treatment is helping.

Follow-up after initiation or dose changes should be timely. Early contact can identify activation, worsening anxiety, insomnia, gastrointestinal effects or emerging suicidal thoughts. Older adults may be reluctant to report adverse effects because they do not want to “cause trouble”, so specific questions are valuable. Carers can provide observations, but the patient’s own preferences and experience must remain central wherever capacity allows.

Digital systems can support reminders, medication histories and communication, yet technology needs human oversight. The reliability of a clinical workflow depends on how information is entered, checked and acted upon, much like a custom HDL simulation depends on testing the design rather than trusting an attractive interface. A medication app should complement, not replace, pharmacist review and clinical judgement.

Supporting recovery beyond the prescription

Antidepressants are one part of care. Behavioural activation, social connection, psychological therapy, exercise suited to ability, sleep routines, meaningful activity and treatment of pain can all support recovery. Pharmacists can reinforce small, specific goals: walking to the letterbox, attending a local Men’s Shed, calling a friend or booking a follow-up appointment. These steps should be realistic for the person’s mobility, finances and living situation.

Social prescribing and community services can be particularly valuable for older Australians who have become isolated after retirement, bereavement or relocation. Local council programs, neighbourhood centres, Carer Gateway, aged-care supports and Aboriginal community-controlled health services may provide practical or social assistance. In metropolitan Sydney or Melbourne, the challenge may be navigating multiple services; in regional Queensland or Tasmania, it may be finding a psychologist or psychiatrist with timely availability.

Pharmacists should also watch for alcohol dependence, misuse of sedatives and medicine-related self-harm risk. A non-judgemental approach makes disclosure more likely. If a patient is collecting medicines early, stockpiling tablets or expressing hopelessness, the issue should be addressed directly and escalated according to risk. Safe supply arrangements, supervised administration and involvement of trusted supports may be needed while urgent mental health care is organised.

Care is strongest when the older person’s goals guide the medication plan. Some may prioritise staying independent at home; others may want better sleep, enough energy to visit grandchildren or relief from distressing pain. Reviewing medicines through those goals helps clinicians balance benefit and harm, avoid unnecessary polypharmacy and recognise when a treatment needs changing.

Depression in an older adult deserves the same seriousness as depression at any age, with added attention to frailty, comorbidities, cognition, function and practical access. Community pharmacists can make a meaningful difference by identifying changes early, checking the whole regimen, supporting safe use and keeping communication open across the care team. Build these checks into everyday dispensing, medication reviews and follow-up conversations so that treatment remains safe, personal and responsive over time.